Emerging Opportunities and Key Players in the Global Tangential Flow Filtration Market

-

The global tangential flow filtration market is a consolidated market. The market is estimated to grow to USD 3.6 billion by 2028 from USD 1.9 billion in 2023, at a CAGR of 13.5%. TFF market can be attributed to technological advancements in TFF over normal flow filtration, rising R&D spending, growing pharmaceutical & biotechnology industries, and stringent regulatory requirements. On the other hand, the high capital investments required to set up new production facilities are expected to hinder market growth.

The global tangential flow filtration market is a consolidated market, with many large, medium-sized, and small market players. The global tff market was dominated by Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker Hannifin Corporation (US), Repligen Corporation (US), Alfa Laval Corporate AB (Sweden), Andritz (Austria), Meissner Filtration Products, Inc. (US), Antylia Scientific (US), Donaldson Company, Inc. (US), Koch Separation Solutions (US), Sterlitech Corporation (US), Synder Filtration, Inc (US), PendoTECH LLC (US), Microfilt India Pvt. Ltd. (India), BIONET (Spain), Sysbiotech GmbH (Austria), Hangzhou Cobetter Filtration Equipment (China), FORMULATRIX, Inc (US), Mantec Technical Ceramics (UK), Smartflow Technologies, Inc. (US), Tami Industries (France), SPF Technologies (US), NovaSep (France), and ABEC, Inc. (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607

Danaher Corporation (US)

Danaher is a prominent player in the tangential flow filtration market owing to its strong portfolio of filtration products, including membranes and systems. Danaher Corporation has witnessed a consistent increase in its revenue in the last three financial years. This increase can be attributed to strategic agreements, acquisitions, and expansions. For instance, in the last three years, Danaher has engaged in acquisitions and agreements with General Electric Life Sciences (US) and Sartorius AG (Germany).

Merck KGaA (Germany)

Merck KGaA is one of the leading players in the tangential flow filtration market. Merck Millipore has expanded its position as the most profitable technology and solutions supplier in the TFF industry by offering leading-edge products for biotechnology & pharmaceutical companies and the advancement of cell and gene therapy. With a strong geographic presence, a broad portfolio of tangential flow filtration products, and continuous expansion in developed and developing regions, the company is expected to grow at a high rate in the TFF market during the forecast period.

Sartorius AG (Germany)

Sartorius provides an extensive range of TFF products for end users such as biopharmaceutical & pharmaceutical companies, CMOs, and CROs. The company has actively engaged in strategic expansion owing to the increasing demand for its products. During the past three years, Sartorius increased its geographic presence across China, the UK, South Korea, the US, and France through the establishment and expansion of manufacturing facilities and customer interaction centers to support the significant global demand for pharmaceutical filtration products, especially for the development and manufacturing of COVID-19 therapies and vaccines. With a strong geographic presence and continuous expansions in developed and developing regions, the company is expected to grow in the TFF market during the forecast period.

Related Links

https://www.marketsandmarkets.com/Market-Reports/tangential-flow-filtration-market-72081607.html

https://www.marketsandmarkets.com/PressReleases/tangential-flow-filtration.asp

https://www.prnewswire.com/news-releases/tangential-flow-filtration-market-worth-3-6-billion--marketsandmarkets-301831872.html

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more